Expanding TB screening, preventive therapy offers SA a possible return on investment — WHO study
SA has one of the world’s highest TB burdens, driven by its large HIV epidemic
20 March 2024 - 05:00
Expanding screening and preventive treatment for people at high risk of tuberculosis would deliver a substantial return on investment with a potential benefit of $39 for every $1 spent in SA, according to a World Health Organisation (WHO) study.
The modelling study developed with the governments of SA, Brazil, Georgia and Kenya is expected to help countries push for more resources to meet the commitments agreed to by heads of state at the 2023 UN High Level Meeting on TB...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.